Drug makers to map out guideline over third-party support

The Korea Pharmaceutical Manufacturers Association said it will launch its task force team to draw up guidelines aimed at specifying in detail the scope of financial support over the pure scientific events.

The task force team includes even representatives from GlaxoSmithKline and BMS Korea. These foreign-invested pharmaceutical firms aim to devise more rational approaches over the support o...